Connect with us


FDA Flags Another Eyecare Product for Potential Bacteria Contamination

An Indian pharmaceutical company is at the center of three eyecare product contamination warnings this month.




The U.S. Food and Drug Administration this week issued a warning advising consumers and eyecare professionals to discontinue the use of Deslam Pharma’s Artificial Eye Ointment.

FDA officials cited concerns of a possible bacteria contamination. The agency noted the connection with a warning earlier this month against the use of EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears.

All three products are produced by Indian pharmaceutical company Global Pharma Healthcare Private Limited. All three are sold over the counter.

On Feb. 1, the Centers for Disease Control and Prevention announced a nationwide health alert. The CDC said it was investigating a disturbing rise in Pseudomonas aeruginosa infections across multiple states. Early discoveries led investigators to signal out Global Pharma Healthcare’s artificial tears products as potential sources. There have been 55 identified cases across 12 states of the rare form of the highly drug-resistant bacteria P. aeruginosa.

On Feb. 2, the FDA recommended a recall of the products, in part, due to Global Pharma Healthcare’s numerous manufacturing violations, including:

-Lack of appropriate microbial testing


-Formulation issues (the company manufactures and distributes ophthalmic drugs in multi-use bottles, without an adequate preservative)

-Lack of proper controls concerning tamper-evident packaging

The FDA then placed the company on import alert, preventing these products from entering the U.S.

Global Pharma Healthcare initiated a voluntary recall of its artificial tears products on Feb. 2. The company agreed to a recall of its eye ointment on Feb. 22.



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular